Skip to main content

Table 1 Gene sets altered in KAE609-treated and PA21A092-treated mutant parasites

From: Metabolic responses in blood-stage malaria parasites associated with increased and decreased sensitivity to PfATP4 inhibitors

Gene set description

Ngene

Percentage of altered genes (%)

Dd2A211V

Dd2

NF54

KA09a

PA92a

PA92b

HXNc

APId

FOSe

Respiratory chain proteins

48

18.8

22.9

8.3

0.0

0.0

2.1

Mitochondrion electron flow

37

16.2

18.9

10.8

2.7

0.0

0.0

Biogenesis of cytochrome oxidase

29

13.8

6.9

6.9

3.4

0.0

3.4

Copper transport

21

28.6

14.3

14.3

4.8

0.0

0.0

Centriole proteins

21

19.0

23.8

14.3

0.0

0.0

4.8

Cytochrome C biogenesis

18

22.2

22.2

11.1

5.6

0.0

0.0

Mitochondrial disulphide relay system

13

15.4

7.7

15.4

7.7

0.0

0.0

Lysine methylation and demethylation

11

18.2

18.2

9.1

0.0

0.0

0.0

  1. KA09 KAE609-treated mutants, PA92 PA21A092-treated mutants
  2. aThis work
  3. bPA92, PA21A092-treated Dd2 [16]
  4. cHXN, hypoxanthine-limited NF54 [14]
  5. dAPI, apicoplast-disrupted NF54 [17]
  6. eFOS, fosmidomycin-treated NF54 [15]